Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00762398 · ClinicalTrials.gov registry record
Evaluation of the Accuracy and Precision of the Masimo Labs Pulse-Hemoglobin-Meter Monitor in Surgical Patients
A clinical trial, sponsored by University of California, Irvine.
- Terminated
- Registry status
- 40
- Enrollment target
NCT00762398 is a clinical trial that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 40 participants.
The verdict
NCT00762398 was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The Masimo monitor can measure hemoglobin level noninvasively and accuratly
Interventions
- DEVICE Masimo hemoglobin-meter
- BIOLOGICAL drawing blood sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00762398
The ClinicalTrials.gov registry entry for NCT00762398 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Masimo hemoglobin-meter is the first listed.
NCT00762398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00762398 about?
NCT00762398 is a clinical study titled "Evaluation of the Accuracy and Precision of the Masimo Labs Pulse-Hemoglobin-Meter Monitor in Surgical Patients". The Masimo monitor can measure hemoglobin level noninvasively and accuratly
What is the current status of trial NCT00762398?
This trial is currently terminated. The enrollment target is 40 participants. The study started on 2008-09. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00762398?
The interventions under investigation include: Masimo hemoglobin-meter (DEVICE), drawing blood sample (BIOLOGICAL).
Who is sponsoring clinical trial NCT00762398?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.